Drug distributor Reckitt Benckiser Group agreed to a $700 million settlement with six U.S. states over claims that the company improperly marketed and promoted the opioid-addiction treatment Suboxone. The marketing resulted in state Medicaid funds being improperly spent on the …
Source: Claims Journal

Drug distributor Reckitt Benckiser Group agreed to a $700 million settlement with six U.S. states over claims that the company improperly marketed and promoted the opioid-addiction treatment Suboxone. The marketing resulted in state Medicaid funds being improperly spent on the …
Source: Claims Journal